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Effective, reproducible, and scalable methods for DNA–lipid assembly are important for the success of non-viral vectors in in vivo gene
therapy. We hypothesized DNA–lipid assembly would be optimal if started from a liquid monophase where both DNA and lipids separately form
molecular or micellar solutions prior to mixing, without preexisting condensed lipid phases, thus allowing DNA–lipid assembly under conditions
close to equilibrium. Previously, we found that mixing plasmid DNA, 1-palmitoyl-2-oleoyl-3-sn-phosphatidylcholine (POPC), cholesterol and a
cationic lipid, 1, 2-dioleoyl-3-(trimethylammonio) propane (DOTAP) in 50% (v/v) aqueous ethanol spontaneously produced an optically
transparent solution. Upon ethanol removal, DNA–lipid nanoparticles (Genospheres™) were formed. For comparison with well-known
technologies, different DNA–lipid particles were prepared by interaction of plasmid DNA and stable or ethanol-destabilized lipid vesicles by
combining the components in water or 30% (v/v) aqueous ethanol, respectively. Among the three studied DNA–lipid assembly methods, only
Genospheres combined the properties of small size (less than or around 100 nm), high incorporation of both lipid and DNA, high degree of DNA
protection (dye accessibility 5–12%), a narrow distribution of particle density and when immuno-targeted, the highest transfection efficiency in
HER2-overexpressing cells in vitro. We conclude that the Genosphere assembly methodology offers advantages for the development of effective,
scalable and targetable non-viral gene delivery vectors.
© 2006 Elsevier B.V. All rights reserved.Keywords: Non-viral gene delivery; DNA–lipid complex; Nucleic acid encapsulation; HER2 targeting1. Introduction
Gene therapy is a potential therapeutic strategy for the treatment
and cure of inherited diseases such as cystic fibrosis and diseases
that are acquired, such as cancer. Lipid based vectors are seen as aAbbreviations: DMSO, dimethyl sulfoxide; FRET, fluorescence resonance
energy transfer; HEPES, 2-(4-[2-hydroxyethyl]piperazino)ethanesulfonic
acid]); HBS, 5 mM HEPES, pH 7.4, 144 mM NaCl; PEDL, particles formed
from ethanol-destabilized liposomes; PEG-DSPE, N-[ω-methoxy-(poly(oxy-
ethylene)-α-oxycarbonyl]-DSPE (PEG mol. weight 2,000); PEG-DSG, 1,2-
distearoyl-sn-glycerol 1-(methoxypoly(ethylene glycol) ether. (PEG Mol.
weight 2,000)
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doi:10.1016/j.bbamem.2006.03.020promising tool, overcoming many of the immunogenic side effects
associated with viral carriers for gene delivery.
An ideal carrier should be small, have the ability to evade the
RES system to reach remote diseased sites such as tumors and
be able to deliver the intact genetic material intracellularly at the
target cell. The carrier must also be easily modified in terms of
altering composition and/or incorporation of targeting ligands to
suit specific applications.
Presently, methodologies for DNA–lipid particle production
include a liquid–liquid phase separation step, the presence of
lipid solubilizing detergent, DNA interaction with pre-formed
liposomes or a drying and rehydration step. We hypothesized
that DNA–lipid assembly would be improved if occurring
within a liquid monophase where both DNA and lipids were
separately molecularly/micellarly soluble prior to mixing,
without pre-existing condensed lipid phases, thus allowing
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affect the assembly, the organic solvent component should be
removed without separation of the system into two liquid phases
or to complete dryness.
Previously, we found that mixing plasmid DNAwith neutral
(POPC, Cholesterol) and cationic (DOTAP) lipids in an
aqueous/organic solvent monophase where initially no lipid
condensed phases were observed, spontaneously produced an
optically transparent solution. Upon solvent removal, we
observed that small DNA–lipid nanoparticles were formed
(Genospheres™) [1]. In this study, we compared the DNA–
lipid particles prepared by the monophase assembly (in
particular, containing 50% (v/v) ethanol) with particles prepared
by two well known methodologies; interaction of DNA with
stable or 30% (v/v) ethanol-destabilized lipid vesicles as
described in the literature by Felgner et al. [2] and Maurer et
al. [3], respectively. The particles were characterized by: DNA
compactness, lipid/DNA and cationic/neutral lipid proximity,
DNA exposure; lipid lamellarity; compositional homogeneity;
completeness of DNA and lipid incorporation; and in vitro
transfection in a non-targeted or ligand-(antibody scFv
fragment)-targeted variant. The data suggested that the Geno-
spheres technology platform may offer advantages for the
manufacture of pharmaceutical gene delivery formulations.2. Materials and methods
2.1. Materials
1,2-Dioleoyl-3-(trimethylammonio)propane (DOTAP), 1-palmitoyl,2-
oleoyl-3-sn-phosphatidylcholine (POPC), (N-(7-nitro-2,1,3-benzoxadiazol-4-
yl)dipalmitoyl-phosphatidylethanolamine) NBD-PE and N- CAP-carboxy-
fluorescein- phosphatidylethanolamine (CFPE) were purchased from Avanti
(Alabaster, AL) and used without further purification. Cholesterol (Chol) was
purchased from Calbiochem (San Diego, CA). Stock solutions of lipids
dissolved in ethanol (Gold Shield, Hayward, CA) were stored at −20 °C. N,
N-di-[3H] methyl-N,N-diocadecylammonium bromide ([3H]-DDAB]), [1α, 2α
(n)-3H] cholesterol ([3H]-Chol) (Amersham Pharmacia Biotech, Piscataway,
NJ) and phosphatidylcholine, L-a-dipalmitoyl [dipalmitoyl-1-14C], (American
Radiolabeled Chemicals, Inc., St. Louis, MO) were stored at −80 °C prior to
use.
Purified Firefly luciferase and D-(−) luciferin were obtained from Roche
(Indianopolis, IN). PicoGreen®, OliGreen®, YOYO-1®, EtHD-2 (ethidium
homodimer-2), 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine-5,5′-
disulfonic acid (DiIC18 (3)-DS), 1,1′-dioctadecyl-3,3,3′,3′-tetramethylindocar-
bocyanine perchlorate (DiI(3)), bis-(3-propyl-5-oxoisoxazol-4-yl)pentamine
oxonol (oxonol (VI)) and anti-fluorescein/Oregon Green rabbit polyclonal
IgG Fab fragment were purchased from Molecular Probes (Eugene, OR).
Lipofectamine 2000 was purchased from Invitrogen (Carlsbad, CA) while
spermidine was obtained from Sigma (St. Louis, MO). Cell culture media was
purchased from the UCSF cell culture facility (UCSF, San Francisco) and cells
were obtained from ATCC (Rockland, MD). F5-PEG-DSPE conjugate was
prepared from the purified anti-HER2 scFv, F5, by conjugation to the
maleimide-activated PEG termini of the PEG-DSPE lipid anchor through an
engineered c-terminal cysteine as described previously [4]. Other reagents of the
highest possible grade were purchased and used without further purification.
2.2. Light scattering of lipid solutions of varying ethanol content
A DOTAP/POPC/Chol/PEG-DSPE (molar ratio 6/15/10/0.16) lipid solution
was prepared from stock lipid solutions in ethanol. The mixture was filtered
through a 0.2 μm polycarbonate membrane (Whatman, NJ) at 60 °C to removeany large particles that would interfere with the measurements. The filtrate was
divided into four round-bottomed flasks and evaporated under vacuum; the
resulting lipid films hydrated in the desired organic solvent/5% (w/w) dextrose
solution followed by brief mixing. The lipid solutions were diluted to 2.1 mM
phospholipid in their respective organic solvent containing dextrose solution,
and the light scattering intensity was determined by photon correlation
spectroscopy using a Nicomp C370 particle size analyzer (Particle Sizing
Systems, Santa Barbara) at 632.8 nm at 23 °C and 55 °C by reading the
scattering event frequency at constant gain. Alternatively, light scattering was
measured a 90° angle using a fluorescence spectrometer (Fluorolog, Jobin Yvon
Spex, NC) at λex/em=633 nm with 1 nm slit widths, using a stirred, thermostated
cell holder (±0.1 °C).
2.3. DNA–lipid particle preparation
A bacterial plasmid containing firefly luciferase gene under the control or
early cytomegalovirus promoter (pCMV/luc+) and a penicillin resistance gene
was constructed as described previously [5]. E. coli transfected with pCMV/luc+
were selected on an ampicillin agar plate and grown in LB medium with
ampicillin (50 μg/ml). The plasmid was extracted and purified using the
EndoFree Plasmid Giga kit from Qiagen (Chatsworth, CA.) The plasmid
concentration was determined by absorbance at 260 nm (ε=6600 l mol−1 cm−1)
and purity by calculating the ratio A260 nm/A280 nm (Shimadzu, UV160U). DNA
is considered to be sufficiently protein free with an A260 nm/A280 nm ratio of at
least 1.85. An siRNA duplex that was shown to have specific gene inactivation
of an adaptor protein Shc A [6], which has been implicated in many types of
receptor mediated cell signaling was obtained from Dharmacon (Layafette, CO)
(AA-N19 mRNA Target 5′→3′; AACUACUUGGUUCGGUACAUGG).
Phosphorothioate modified oligonucleotide was obtained from MWG-Biotech
AG, NJ and had a sequence shown to have specific inhibition of up-regulated
genes implicated in colon cancer (5′CACTGCCAATCTCATGGTCG 3′) (LC
Chen and NM Lee, California Pacific Medical Center Research Institute,
personal communication). Both siRNA and oligo were supplied in a lyophilized
form and were rehydrated with deionized water with concentrations determined
by absorbance at 260 nm using the expressions that 1O.D equates to 40 μg/ml
siRNA and 33 μg/ml oligonucleotide.
From a plasmid DNA (pCMV/luc+, 4.5 kbp) stock solution of 2 mg/ml in TE,
pH 8.0 buffer, plasmid DNA, siRNA or oligonucleotide was diluted to 0.4 mg/ml
in 5 mM HEPES–Na buffer, pH 7.4 and used in the preparation of complexes.
For fluorescence resonance energy transfer (FRET) studies, intercalating dyes
were added to aliquots of the plasmid DNA solution at a concentration of 1 dye
per 200 bp and incubated at room temperature for 1 hour to allow adequate time
for complete dye binding before further processing. A stock lipid solution of
DOTAP, POPC, and Chol dissolved in ethanol at a molar ratio of 6:15:10 was
used in the preparation of the complexes. The lipid mixture was added to the
DNA as described below at a ratio of 6 nmol DOTAP per 1 μg of DNA. This
corresponds to a 2-fold excess of cationic charge from DOTAP over the anionic
phosphates of each nucleotide. Fluorescent lipid markers DiI(3), DiI(3)-DS and
NBD-PEwere added if required to the lipid mixtures prior to complex formation,
at a molar ratio of 2:1 to the intercalating DNA dye in the final complex.
2.3.1. Lipoplex
The complexes made from mixing cationic liposomes and DNA together are
commonly referred to as lipoplexes [7]. An aliquot of the lipid stock solution
containing 3.1 μmol (total lipid) lipid was brought to dryness under vacuum and
re-hydrated with 0.5 ml 5 mM HEPES, pH 7.4. The lipid suspension was
vortexed and sonicated to clarity (5 min) in a bath sonicator (Laboratory
Supplies Company, Hicksville Inc., NY) to produce liposomes [5]. Stock DNA
solution was diluted twice to a final volume of 0.5 ml in 5 mM HEPES (pH 7.4)
and added to the liposome solution rapidly at room temperature. These
lipoplexes were used within 1–2 h after preparation.
To validate the use of DiIC18(3) and DiIC18(3)-DS as appropriate FRET
markers for cationic and neutral lipids, respectively, sonicated liposomes were
prepared containing each dye separately in a 1:1 molar mixture with DOPE as
described above. Lipoplex complexes were prepared by mixing liposomes with
DNA in a ratio of two dyes per DNA phosphate. After incubation at room
temperature for 30 min, the suspensions were briefly centrifuged (13,000 rpm
for 5 min). An estimate of the amount of fluorescence lipid remaining in solution
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after centrifugation, by dissolving known aliquots in 0.1% Triton X-100 and
measuring intensities using (λex 549 nm/λem 566 nm).
2.3.2. Particles prepared from water/organic solvent mixtures
Aliquots (3.1 μmol) of the lipid mixture stock solution were diluted with
appropriate volumes of ethanol and 5 mM HEPES, pH 7.4 buffer and ethanol to
bring the concentrations of ethanol to 30% (v/v) or 50% (v/v), in a final volume
of 0.5 ml. Alternatively, the lipid was dried and re-dissolved in the appropriate
organic solvent/aqueous mixture. In separate tubes, aliquots of the nucleic acid
stock solution (containing 100 μg) were mixed with appropriate volumes of
5 mM HEPES, pH 7.4 buffer and organic solvent to obtain 0.5 ml of a solution
containing the desired water miscible solvent concentration. The nucleic acid
and lipid solutions were pre-warmed at 60 °C, and the nucleic acid solution was
added rapidly to the lipid solution of corresponding solvent concentration,
pipetting up and down 4–5 times to ensure complete mixing. The mixtures were
further incubated at 60 °C for 5 min, then removed from the water bath and
allowed to reach room temperature. The mixture was dialyzed exhaustively
against 5 mM HEPES, pH 7.4 buffer with or without 0.15 M NaCl (as indicated
below) at room temperature, using dialysis tubing with a molecular weight cut-
off of 6000–8000 Da.
2.3.3. HER2 targeted particles
HER2-targeted lipid–DNA particles were prepared using the method
previously described for liposomes [4]. HER2-specific, highly internalizable
single chain Fv was conjugated via a c-terminal cysteine group to a thiol-reactive
amphiphilic lipid anchor maleimido-PEG-DSPE, and the micelle-forming
conjugate (F5-PEG-DSPE) was purified by size exclusion chromatography.
F5-PEG-DSPE was incubated with the DNA–lipid particles in HEPES–saline
buffer (5 mM HEPES–Na, 144 mM NaCl, pH 7.4) at 37 °C overnight with
typically the amount of conjugate equal to 5 μg antibody added per μmole of
POPC in the sample. The antibody conjugate is presented in a solution also
containing a proportion of cysteine quenched maleimide-PEG-DSPE [8,9] and
therefore non-targeted control samples were heated in the same manner using an
identical amount of additional PEG-DSPE (0.73 nmol PEG-DSPE per μmol PC
in sample). Attachment of the antibody is achieved by spontaneous incor-
poration of the lipophilic (DSPE) portion of the conjugate into the outer lipid
layer of the particles during the incubation. Allen and coworkers describe this
technique in detail [10]. Genosphere samples were stored at 4 °C until use. To
maintain sterility of the lipoplexes, DNA, sonicated liposomes, and F5-PEG-
DSPE solutions were filter-sterilized and combined under aseptic conditions.
2.4. Particle size analysis
The volume-weighted mean and standard deviation (SD) of the particle
diameter distribution was determined in 5 mM HEPES–saline pH 7.4 at 23 °C
using quasielastic light scattering (Nicomp C370 Particle Size Analyzer
(Nicomp Particle Sizing Systems, Santa Barbara, CA) using the solid particle
mode and Gaussian analysis for chi of 3.0 or less, or SDP analysis for chi over
3.0. The measurement of particle sizes for the studies reported in (Fig. 3A, B)
was made by a Beckman PCS Particle Sizer, using the volume weighted size and
standard deviation analysis function.
2.5. PicoGreen dye accessibility and particle DNA quantification
assay
Aliquots (100 μl) of the particle suspensions containing approximately
700 ng/ml of DNAwere placed in a 96-well mictotiter plate, diluted with 100 μl
of HEPES–saline, pH 7.4, and mixed with 2.5 μl of the PicoGreen DNA
intercalating dye stock solution (Molecular Probes, Inc., OR). DNA concen-
tration standards in the range of 50–1000 ng/ml were prepared in the same
manner using pCMV/luc+ plasmid solutions instead of the particle suspensions.
To provide for 100% DNA-accessibility reference, a 2× dissociation solution
(10% (v/v) DMSO, 1% (w/v) Zwittergent 3–14 in HEPES–saline) was used as a
particle suspension diluent instead of HEPES–saline, and the samples were
incubated at 60 °C for 30 min to solubilize the lipid components of the particles.
The samples were cooled down to the room temperature, mixed with PicoGreendye stock and. incubated for 20 min in the dark. The fluorescence intensity of the
samples was determined in quadruplicate using microplate fluorometer (FL-
600A, Bio-Tek Instruments, Inc.) equipped with a 485/20 nm bandpass
excitation filter and a 530/25 nm bandpass emission filter. The percent of dye-
accessible DNAwas determined as the fluorescence intensity ratio between non-
dissociated particle samples and dissociated (solubilized) particle samples times
100%, and the total amount of DNA was quantified from the fluorescence
intensity of the dissociated particle samples using the concurrently run standard
curve. Picogreen was used for plasmid DNA and siRNA quantification, whereas
Oligreen was used for oligonucleotide determination in a similar manner as
described above.
2.6. FRET studies
2.6.1. DNA compactness
The FRET efficiency between the DNA-intercalating fluorophores YOYO-1
(λex 470 nm/λem 509 nm) and EthD-2 (λex 530 nm/λem 620 nm) forming a
donor–acceptor pair was used to characterize the compactness of the complexed
DNA. Each dye was added to the DNA at the ratio of 1 dye per 200 bp. A
parameter E reflecting the energy transfer efficiency was calculated from the
measured fluorescence intensities (Fluorolog, Jobin Yvon Spex, NC) (I) as
follows:
E ¼ F
F0
 1 ð1Þ
F0 ¼ ðI
k620 nm
EthD2 þ Ik620 nmYOYO1Þ
ðIk509 nmEthD2 þ Ik509 nmYOYO1Þ
ð2Þ
F ¼ I
k620 nm
YOYO1þEthD2
Ik509 nmYOYO1þEthD2
ð3Þ
i.e., F0 was determined from the measurements when only one of the probes was
present, and therefore, was indicative of the spectral intensities at zero FRET
efficiency, and F was determined when both probes were present, and FRET
may have occurred. The measurements were taken at an excitation wavelength
of 470 nm; the superscripts and subscripts in formulas (2) and (3) refer to the
emission wavelengths and the particular dye(s) measured, respectively.2.6.2. Relative distances between DNA and cationic lipid or neutral lipid
YOYO-1 labeled DNA and either DiI(3) (cationic) or DiI(3)-DS (neutral)
lipid probes were used. The FRET efficiency parameter (E) was determined as
above, using the fluorescence intensities of the emission maxima of the
respective probes (DiI(3), DiI(3)-DS at 566 nm).
2.6.3. Relative proximity of cationic lipid and neutral lipid within the complexes
The lipid probes NBD-PE (λex 465 nm/λem 530 nm) and DiI(3) (λex 549 nm/
λem 566 nm) were used as a FRET donor/acceptor pair to characterize the
proximity of cationic lipid and neutral dialkyl-lipid in the DNA–lipid particles
and lipoplexes. The lipid dyes were added at 0.1 mol% total lipid and the
parameter E was calculated as above.
In the FRET studies outlined above, the samples can become diluted during
dialysis. To account for the fluorescence intensity variations due to particle
dilution, the fluorescence intensity was normalized to the total amount of
phosphate-containing compounds in the particle preparation [11]. Complexes
prepared without fluorescent probes were used to correct for background
scattering.
2.7. Particle lamellarity determination
The proportion of the carboxyfluorescein-labeled phospholipid headgroups
(CFPE) exposed on the particle outer surface, i.e., whose fluorescence was
quenched by a membrane-impermeable quencher, anti-fluorescein Fab′ frag-
ment was considered indicative of the particle lamellarity. This allows one to
obtain structural information on the number of enclosed bilayers contained
within the particle. DNA–lipid particles and unilamellar liposomes (control)
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(6:15:10 molar ratio) with CFPE (0.5 mol% of POPC content) as described
above. The particle samples were diluted to approximately 5 μM POPC in HBS,
pH 7.4 and fluorescence intensity was measured at (λex 497 nm/λem 528 nm)
before and after the addition of 12 μl of 0.5 mg/ml anti-fluorescein/Oregon
Green IgG stock solution per 0.6 ml of sample. No further quenching was seen
above this ratio of anti-fluorescein IgG to CFPE. Quenching was expressed as
the percentage drop in CFPE emission after addition of antibody.
2.8. Sucrose density gradient centrifugation
Sucrose gradients (0–13% v/w) in HEPES-buffered saline were reproduc-
ibly prepared using a precision dispensing system that consisted of two P-500
high precision programmable pumps, a GM-1 gradient mixer, a MV-8 valve, and
an LCC-500 FPLC system controller (Amersham Pharmacia Biotech). The
controller was programmed to dispense sequentially six linear 0–100%
gradients of solvent B (13% sucrose in 5 mM HEPES–saline, pH 7.4) in
solvent A (5 mM HEPES–saline, pH 7.4) into six Beckman Ultra-Clear
13×51 mm ultracentrifuge tubes at the total dispensed volume of 4 ml per tube.
Sample aliquots (200 μl) were carefully applied onto the top of the gradient
solution, and the tubes were centrifuged at 192,000×g for 10 h at 22 °C
(Ultracentrifuge L8-70M, Beckman) using an SW50.1 rotor. After centrifuga-Fig. 1. The structures of fluorescent, non-fluorescent lipid components and DNA inter
(B) Chol; (C) POPC; (D) PEG-DSPE; (E) PEG-DSG; (F) DiIC18(3); (G) CFPE; (Htion, the tubes were illuminated from the top and photographed against a black
non-reflective background to detect the location of particle bands by light
scattering. The gradients were divided into 150 μl fractions, starting from the
top, and the fractions were analyzed for lipid content by 14C and 3H radioactivity
measurements (for neutral and cationic lipid, respectively), particle size, and
nucleic acid content (by PicoGreen or Oligreen). The sucrose solution densities
of the fractions were calculated from the measurements of sucrose concentra-
tions using a refractometer (Leica AR200, Leica Microsystems, IL) and
conversion to density by using tables found in [12].
2.9. In vitro transfection
HER2-overexpressing human breast adenocarcinoma cells SK-BR-3 cells
were cultured in McCoy's 5A medium supplemented with 10% (v/v) fetal
bovine serum, 100 μg/ml of streptomycin sulfate and 100 U/ml of penicillin G at
37 °C, 5% CO2. The cells were plated at a density of 150,000 cells per well in 12
well plates (Corning) and acclimated overnight in the above media without
serum or antibiotic supplements. The final media volume in each well was 1 ml
and each well received 1 μg of pCMV/luc+ as either Lipofectamine 2000-DNA
complex (using transfection conditions recommended by the Lipofectamine
manufacturer), free DNA, or a DNA–lipid preparation. The cells were exposed
to the DNA–lipid samples for 12 h, and Lipofectamine 2000 complexes for 6 h,calators used in this study. Molecular structures denoted as follows; (A) DOTAP;
) DiIC18(3)-DS; (I) NBD-PE; (J) YOYO-1 and (K) EthD-2.
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supplemented growth medium added to a final volume of 1 ml per well. After
further incubation for 24 h, the cells were washed with PBS twice, and then 1 ml
PBS (with 3 mM EDTA) added to each well to detach cells. After 5 min cell
suspension was thoroughly mixed and transferred to a clean Eppendorf tube and
centrifuged at 14,500×g for 2 min. The supernatant was removed, and the pellet
washed with PBS. After removal of PBS by centrifugation as above, 0.1 ml
sodium phosphate 0.1 Mwas added and tubes quickly frozen at −80 °C. Cellular
disruption was achieved by 2 freeze–thaw cycles, and a clear cell lysate was
obtained following centrifugation at 14,500×g for 30 s.
Luciferase in the supernatants was quantified by luminometry (Monolight
3010, Analytical Luminescence Laboratory). An aliquot (100 μl) of freshly
prepared substrate solution containing 0.5 mMD(−)-luciferin, 30 mM Tris–HCl
pH 7.8, 3 mM ATP, 15 mM MgSO4, 10 mM DTT, and 0.2% Triton X-100 was
injected into the luminometer cuvette containing 20 μl of the cell lysate, and
after a 2-s delay, the luminescence was read for 10 s. The luciferase standards
were prepared by 10-fold serial dilutions of the 0.5 mg/ml firefly luciferase stock
made with the cell lysis buffer to a typical concentration range of 5.10−9 to
5.10−5 mg/ml, and read in a similar manner. Protein concentration in the cell
lysates was measured using a Micro BCA protein assay (Pierce, Rockford, IL)
using bovine serum albumin as the standard. The amount of luciferase was
expressed in ng luciferase per mg of cell lysate protein.Fig. 2. The light scattering intensities of DOTAP/POPC/Chol/PEG-DSPE (molar
ratio 6/15/10/0.16) lipid mixtures in 5% (w/w) dextrose with varying organic
solvent concentrations. All measurements were made at a phospholipid
concentration of 2.1 mM in (A) ethanol containing solutions at 23 °C (open
diamond) and 55 °C (filled square) or at 23 °C (B) and 55 °C (C) using the following
solvents, dioxane (open square), isopropanol (filled diamond), dimethylformamide
(filled circles) and ethyleneglycol dimethyl ether (open triangle).3. Results
3.1. Determination of suitable aqueous/organic solvent
mixtures to prepare Genospheres
The structures of the fluorescent and non-fluorescent lipid
components used in the present study as well as the fluorescent
DNA binding molecules are shown in Fig. 1. Condensed lipid
phases in solution tend to form particles whose presence may be
detected by increased light scattering. The light scattering
intensities of a lipid mixture, DOTAP/POPC/Chol/PEG-DSPE
(6:15:10:0.16), dispersed in water/water-soluble organic solvent
mixtures of varying organic solvent concentrations was
measured (Fig. 2). The mixtures were measured at two
temperatures, 23 °C and 55 °C. For each solvent tested, there
was appreciable scattering intensity at lower organic solvent
concentrations (less than 30% (v/v)) at both temperatures.
However, at 55 °C, in the case of isopropanol, ethanol and
ethylene glycol dimethyl ether, higher organic solvent concen-
trations caused the scattering intensity to drop to the level of the
background solvent, indicating the disappearance of condensed
lipid phases and the formation of a molecular (true) or micellar
solution.
We then prepared plasmid DNA/lipid complexes in aqueous/
organic solvent mixtures using the above lipid formulation at
such organic solvent concentrations, where condensed phases
were absent, to determine if the organic solvent component in
the aqueous/organic solvent mixture affected the properties of
the resultant plasmid DNA–lipid particles. Subjecting the
DNA–lipid particles to sucrose density gradient centrifugation
assessed one such property, particle homogeneity. This
technique allowed separation of lipid-rich (light) and DNA-
rich (heavy) fractions, as well as the removal of free DNA, if
any was present. After centrifugation, all preparations formed
distinct light-scattering bands (Fig. 3A). The particles produced
from 40% (v/v) isopropanol and 50% (v/v) ethanol had a similar
density (1.016–1.02) and almost identical lipid/DNA ratios asthe starting material indicating the particles were homogeneous
with respect to density and composition (Table 1). However,
those particles made in 50% dioxane and 60% (v/v) ethylene
glycol dimethyl ether, produced distinct bands that were lipid
rich and/or heavier DNA rich bands signifying that these
particular solvents may not be optimal for producing homog-
enous complexes.
DNA-binding hydrophilic dyes, such as PicoGreen® greatly
increase their fluorescence upon binding to DNA exposed to the
solution. The increase in the dye fluorescence in the presence of
DNA–lipid particles is proportional to the amount of “dye-
accessible” DNA, i.e., the DNA that is incompletely encapsu-
lated, free, or adsorbed on the particle surface. After the release
Fig. 3. Analysis of nucleic acid-lipid particles produced from various aqueous/organic-solvent mixtures using sucrose density centrifugation (0–13% (w/w) sucrose).
(A) Complexes of formulation DOTAP/POPC/Chol/PEG-DSPE (molar ratio 6/15/10/0.16 nmol/nmol/nmol/nmol per μg plasmid DNA) prepared from 40% (v/v)
isopropanol, 50% (v/v) ethanol, 50% (v/v) dioxane, and 60% (v/v) ethylene glycol dimethyl ether were applied to the top of each column (i-iv respectively) and tubes
centrifuged at 192,000 g for 10 h at 22 °C. (B) Genospheres containing DOTAP/POPC/Chol with the molar ratio of 6/15/10 nmol/nmol/nmol of lipid per μg plasmid
DNA, siRNA or oligonucleotide (i-iii) respectively were prepared and centrifuged as described above. (C) DNA-lipid complexes (DOTAP/POPC/Chol (6/15/10 nmol/
nmol/nmol lipid per μg plasmid DNA) prepared from 0, 20, 30, 40, 50 and 60% (v/v) ethanol were applied to the sucrose gradients (tubes (i-vi) respectively).
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detergent, the fluorescence further increases, now being
proportional to the total amount of DNA contained in the
sample. The ratio of DNA-binding dye fluorescence between
the native and solubilized particles is known as the dye
accessibility and serves as the measure of completeness of the
DNA encapsulation within the lipid [13]. Using this technique,
we observed that the particles produced in either 40% (v/v)
isopropanol and 50% (v/v) ethanol had relatively low dye
accessibilities and when purified on the sucrose gradient the
values were found to be close to the starting material (Table 1).
However, with 50% (v/v) dioxane and 60% (v/v) ethylene
glycol dimethyl ether we observed initially high dye accessi-
bilities, which was reduced by purification on the gradient as a
consequence of non-encapsulated DNA removal. In both cases
the majority of DNA resided in the bottom fraction.
In order to determine if the use of an aqueous/organic solvent
monophase was suitable for encapsulation of other nucleic acid
types, we used one such monophase, a 50% (v/v) ethanol/water
mixture with the above lipid formulation to separately entrap
small double stranded RNAwith 22 bp (siRNA) and short single
stranded DNA with 20 bases (phosphorothioate modified anti-
sense oligonucleotide). We then compared these Genosphere
complexes with Genosphere particles that contained plasmid
DNA (4.5 kbp) in a similar manner as above (Fig. 3B). We
observed the main light scattering bands for the plasmid (i) andTable 1
Characterization of DNA–lipid particles made from various aqueous/organic-solven
gradient
Solvent, % (v/v) Size (nm±S.D. nm) Initial PC/DNA Init
Acc
Isopropanol, 40% 115.8±46.9 14.6±0.5 11.
Ethanol, 50% 116.2±49.4 13.4±0.5 9.
Dioxane, 50% 192.9±58.2 14.1±1.2 32.
Ethylene glycol
dimethyl ether, 60%
552.5±223.7 66.2±2.7 44.
The formulation used was DOTAP/POPC/Chol/PEG-DSPE with the molar ratio of 6/
fraction was measured and sucrose density (g/cm3) calculated as described above.oligo (iii) entrapped complexes to have similar densities
(ρ=1.014–1.017 and 1.016–1.018, respectively), while the
siRNA (ii) sample was slightly more dense (ρ=1.019–1.022).
Some free lipid was observed on the gradient in the case of the
siRNA. The lipid/plasmid DNA and lipid/oligo ratios for their
respective main bands were almost identical to the starting
components (Table 2).
This technique facilitated DNA–lipid interaction in a
medium that initially does not contain lipid condensed phases.
We then compared the particles made from the Genosphere
method, to particles produced by interaction of plasmid DNA
and stable (lipoplex) or ethanol-destabilized lipid vesicles by
combining the components in water or 30% (v/v) aqueous
ethanol, respectively, using the same lipid formulation. The
particles made from ethanol-destabilized liposomes will be
designated as PEDL.
3.2. DNA compaction within the complexes
As an increase in DNA compactness brings distant nucleo-
tide pairs closer to each other, the extent of FRET between the
dyes (YOYO-1 and EthD-2), sparsely and randomly distributed
along the DNA molecule would serve as a direct measure of the
closeness of DNA base pairs and therefore of the DNA
compactness [14]. Indeed, in the absence of DNA compacting
agents, the FRET efficiency parameter (E) values of YOYO-1t mixtures before and after purification by centrifugation on a sucrose density
ial % Dye
essibility
PC/DNA
main band
% Dye Accessibility
of main band
Density (g/cm3)
6±0.4 13.3±0.6 8.9±0.3 1.016–1.017
5±2.7 13.0±0.8 8.5±0.5 1.016–1.017
5±2.6 8.8±0.3 12.8±0.8 1.016–1.017
2±1.6 22.4±1.4 38.7±1.8 1.043–1.047
15/10/0.16 nmol of lipid, respectively, per μg DNA. The refractive index of each
Table 4
Table 2
Characterization of Genospheres made using different nucleic acid types, before and after purification by sucrose density gradient centrifugation
Nucleic acid Initial PC/
nucleic acid
% dye accessibility
(initial)
Size
(initial)a
PC/nucleic acid
(main band)
% dye accessibility
(main band)
Size
(main band)a
Density
(g/cm3)
Plasmid 5.5 kbp 13.3±0.4 3.5±0.2 123±5 13.4±0.5 6.1±0.3 122.5±47 1.014–1.017
siRNA 21 bp 13.9±0.2 18.6±1.1 148.8±57.6 8.4±0.4 17.5±0.9 128.7±62.1 1.019–1.022
Oligonucleotide
20 bases
14.0±1.0 13.8±0.6 105.7±43.4 20.4±1.9 14.5±0.2 117.4±54.5 1.016–1.018
The formulation used was DOTAP/POPC/Chol in the molar ratio of 6/15/10 nmol of lipid, respectively, per μg nucleic acid.
a Size (nm±S.D. nm).
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various water and water/ethanol mixtures tested, while in the
presence of spermidine, a well-known DNA condensing agent
[15], E values increased to 6–8 (Table 3). When the lipid
mixture described above was added to DNA in the form of
liposomes, the value was close to 2. Lower values were ob-
tained when lipid is added in 30% (v/v) and 50% (v/v) ethanol,
i.e., close to 1 in both cases indicating slightly less DNA com-
paction. After dialysis, the Genospheres and PEDL particles
showed E values of 1 and 2.1, respectively. When the salt con-
centration was adjusted to a physiological concentration, all
particles exhibited approximately equal and a rather modest
degree of DNA compaction.
3.3. Validation of the use of cationic and neutral FRET lipid
pairs
The structures of fluorescent lipid dyes DiI(3) and DiI(3)-DS
(Fig. 1) suggested them as good position markers for cationic
and neutral dialkyl lipids, respectively, when used as either a
FRET-donor or acceptor in a multicomponent lipid assembly. In
order to validate this suggestion, we studied the ability of these
dyes to form liposomes and further form complexes with DNA
in a manner characteristic for conventional cationic liposome.
Small sonicated liposomes were prepared with each dye in
combination with DOPE (1:1), and mixed with DNA at a ratio
of 2 dyes per DNA phosphate, which is a common procedure forTable 3
The FRET parameter E of dual labeled uncomplexed DNA, DNA–spermidine
complexes and DNA incorporated into various lipid complexes in different
aqueous media
Sample aqueous ethanol 5 mM HEPES, pH 7.4 HBS, pH 7.4
DNA 0.3 0.6 N/A
DNA+Spermidine 8.4 6.2 N/A
Lipoplex N/A 2.0 1.4
Genosphere 1.2 1.0 0.8
PEDL 1.0 2.1 1.3
EthD-2 and YOYO-1 were added to DNA (1:200 dyes per base pair for both
fluorescent probes) and formulated into various cationic lipid-containing
complexes as described above. E was measured in the various media and for
comparison, also measured for uncomplexed and condensed DNA (with
spermidine). The values shown for Genospheres and PEDL in ethanol/aqueous
mixtures are for 50% and 30% (v/v), respectively. The E values for DNA and
DNAwith spermidine are those measured in 50% (v/v) ethanol and are similar to
values obtained in 30% (v/v) ethanol. Spermidine and sodium chloride were
added from concentrated solutions to give final concentrations of 10 mM and
144 mM, respectively. All measurements were taken at 23 °C.making lipoplexes (1). Upon mixing, turbidity developed in the
DiI(3)/DOPE–DNA liposome sample, and no apparent turbid-
ity developed in the DiI(3)-DS/DOPE–DNA preparation. After
centrifugation approximately 50% of the DiI precipitated from
solution, indicating the formation of charge stoichiometric
complex between the dye liposomes and the DNA, while none
of the DiI-DS liposomes precipitated, as quantified by
fluorescence measurements of the supernatants.
3.4. Determination of closeness of DNA to cationic and neutral
dialkyl lipid in the particles
Similarly, we used the FRET efficiency parameter E between
the DNA bound donor dye YOYO-1 and the fluorescently
labeled DiI(3) (cationic) and DiI(3)-DS (neutral) lipid acceptor
labels to characterize the proximity of the cationic or neutral
dialkyl–lipid components of the particles to the DNA molecule
(Table 4). In a lipoplex, both cationic and neutral lipid labels
were at similar distances from DNA as indicated by the similar
E values. When the lipids were combined with DNA in a 50%
(v/v) ethanol monophase at 60 °C. The cationic lipid attained a
significantly closer proximity to DNA (E=1.6) than did the
neutral lipid (E=0.2), indicating that cationic lipid component
assembled on the DNA molecule first. After the temperature
decreased to ambient, neutral and cationic lipids showed theThe FRET parameter E as measured using YOYO-1 bound DNA as the donor
molecule and either DiIC18(3) (cationic) or DiIC18(3)-DS (neutral) as the
acceptor molecules
Sample 60 °C in
aqueous
ethanol
22 °C in
aqueous
ethanol
22 °C in 5 mM
HEPES, pH 7.4
22 °C in
HBS, pH 7.4
Lipoplex
Cationic N/A N/A 1.9 1.1
Neutral N/A N/A 1.7 1.3
Genosphere
Cationic 1.6 1.5 2.3 1.7
Neutral 0.2 2.0 2.3 2.1
PEDL
Cationic 0.7 2.0 3.2 2.3
Neutral 0.6 1.6 1.5 1.6
FRET measurements were taken at various stages during the preparation
procedure of the complexes and after removal of the organic solvent by dialysis
against 5 mMHEPES, pH 7.4. Sodium chloride was added from a stock solution
to give a final concentration of 144 mM.
Table 6
Size and % dye accessibility of DNA–lipid complexes prepared using lipoplex,
PEDL or Genosphere preparation procedures
Sample Size (nm) % Dye Accessibility
Lipoplex 216.9±100.6 61.4±1.3
Genosphere 66.4±32.8 4.6±0.8
PEDL 86.6±40.5 38.1±0.6
Complexes were prepared as described above using the lipid composition of
DOTAP/POPC/Chol (6/15/10 nmol per μg DNA) with ethanol removal affected
by dialysis against unbuffered saline.
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lipid components joined the cationic lipid in a DNA-enclosing
lipid shell. After dialysis, E increased only slightly for both
probes, suggesting that no major redistribution of the lipid
components in relation to DNA occurred during the removal of
ethanol. In contrast, when the lipids were combined with DNA
at 60 °C in 30% (v/v) ethanol, cationic and neutral lipids were
equidistant from DNA (E=0.6–0.7), suggesting the DNA first
bound to the pre-formed cationic-neutral lipid condensed phase
as a whole. Upon cooling to room temperature, the FRET
efficiency between DNA label and both neutral and lipid
component equally increased (E=1.6–2.0), indicating that
structural rearrangements took place bringing the lipids closer
to DNA; and upon removal of ethanol, the cationic lipid–DNA
proximity further increased (E=3.2). This sequence of events is
consistent with the proposed mechanism of “small multi-
lamellar liposome” formation through DNA-induced rearrange-
ments of ethanol-destabilized lipid vesicles [3]. Increasing the
sodium chloride concentration to 144 mM caused the E
parameter to become smaller, especially between cationic
lipid and DNA in all cases. There was relatively little change
in E with respect to DNA and neutral lipid. This indicates some
further structural rearrangements occur upon exposure to
physiological salt concentrations where the distance from
cationic lipid and DNA become greater. The smallest changes
in E upon adding salt are seen for Genospheres indicating they
may be less susceptible structural changes induced by the ionic
strength of the surrounding media.
3.5. Relative lipid distribution within the particles
To understand how cationic and neutral lipids were
distributed relative to each other, we measured the efficiency
of FRET between two lipid labels, a headgroup-labeled
“neutral” lipid label NBD-CAP-PE serving as a donor, and a
cationic lipid acceptor DiIC18(3) (Table 5). In the absence of
DNA, liposomes prepared by various routes (extrusion of an
aqueous lipid dispersion, or ethanol removal from 30% (v/v) or
50% (v/v) ethanol mixtures) showed fairly efficient FRETTable 5
FRET parameter (E) between cationic and neutral lipids within the various lipid
assemblies measured in aqueous ethanol and buffer at 22 °C and 60 °C
Sample 60 °C in
aqueous
ethanol
22 °C in
aqueous
ethanol
22 °C in 5 mM
HEPES, pH 7.4
22 °C in
HBS, pH 7.4
Lipoplex N/A N/A 1.8 2.2
Lipoplex
‘minus’ DNA
N/A N/A 1.2 1.6
Genosphere 0 1.7 2.4 2.7
Genosphere ‘minus’
DNA
0 0 1.1 1.4
PEDL 1.3 2.3 2.2 2.5
PEDL ‘minus’ DNA 0.8 1.7 2.2 2.5
The neutral donor NBD-PE and the cationic acceptor DiIC18(3) molecules were
incorporated into the formulations as previously described. For each of the
particle-forming methods, replicas were made without DNA (i.e., ‘minus’DNA)
to provide information on how the presence of DNA affects the relative lipid
distributions.between neutral and cationic lipid labels (E=1.1–2.2), and so
did DNA–lipid particles prepared by different routes, suggest-
ing that all these structures contained mixed lipid phases in
which cationic and neutral components were not clearly
separated. In the presence of 30% (v/v) ethanol, even at 60 °C ,
there was relatively efficient FRET between neutral and cationic
lipid components (E=0.8), indicating the presence of a mixed
lipid condensed phase, which is consistent with the light
scattering measurements. In the presence of DNA a further
increase in FRET (E=1.7) was observed, pointing to the
compaction of the lipid phase upon interaction with DNA,
possibly resulting from the exclusion of interdigitating ethanol
molecules. In 50% (v/v) ethanol without DNA at 60 °C, as ex-
pected from the light scattering data, no detectable FRET was
observed between the neutral and cationic lipid until the solvent
was dialyzed away, and liposomes formed. In the presence of
DNA at 60 °C and 50% (v/v) ethanol, the neutral-to-cationic lipid
FRETwas also undetectable, consistent with the observation that
only cationic lipid was bound to DNA under these conditions.
Upon cooling to ambient temperature, the neutral lipid joined the
condensed lipid phase around the DNAmolecule, and the neutral-
to-cationic lipid FRET became efficient (E=1.7). Exposure to
saline caused a small increase in E, roughly to the same extent for
all lipid assemblies. We did, however, observe the presence of
scattering material in 50% (v/v) at 22 °C ethanol (Fig. 2) but did
not measure any detectable FRET, and this suggests that the
particles responsible for the scattering in this case did not contain
both of the probes; for example it is possible that cholesterol is less
soluble at 22 °C in this solvent mixture.
3.6. Size and dye accessibility of particles
We compared the average particle size and dye accessibilities
of lipoplexes, PEDL particles, and Genospheres having the
same composition as those used for FRET proximity studies
(Table 6). The average size of the particles produced using the
lipoplex methodology was over 200 nm, consistent with a
multilamellar structure [16]. The dye accessibility is high
(N60%), suggesting that a substantial amount of DNA is either
adsorbed on the surface of the lipid structure or is incompletely
covered with lipid. Both Genospheres (50% (v/v) ethanol) and
PEDL (30% (v/v) ethanol) preparations consisted of small
particles (100 nm) resembling unilamellar liposomes by size,
but differed in the amount of dye-accessible DNA. This
indicates the particles assembled from the DNA and lipid
components in solution provided for somewhat more complete
Table 8
The fluorescence quenching of CFPE molecules incorporated into the DNA–
lipid assemblies by an anti-fluorescein IgG
Sample % Quenched
Unilamellar liposomes 57.7
Lipoplexes 18.2
Prepared in 20% (v/v) ethanol 53.3
Prepared in 30% (v/v) ethanol 63.7
Prepared in 40% (v/v) ethanol 59.7
Prepared in 50% (v/v) ethanol 49.3
Prepared in 60% (v/v) ethanol 41.2
DNA–lipid complexes comprising of DOTAP/POPC/Chol (6:15:10 molar ratio)
per 1 μg DNA were prepared which included CFPE (0.5 mol% of POPC
content). Fluorescence was measured before and after the addition of anti-
fluorescein/Oregon Green IgG.
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deformation of pre-existing vesicles.
3.7. Particle homogeneity of particles made from water/ethanol
mixtures of varying ethanol concentrations
To assess particle homogeneity, DNA–lipid particles pre-
pared from a range of ethanol concentrations (20, 30, 40, 50 and
60% (v/v)) were subjected to sucrose density gradient as
described before (Fig. 3C). Particles prepared at 0% ethanol
(lipoplex) and 20% (v/v) ethanol formed a single band with
ρ=1.021–1.022. In a 30% (v/v) ethanol preparation, the band
with ρ=1.025 was accompanied by another band at ρ=1.007
which was found to contain practically no DNA (“empty”
liposomes). In a 40% (v/v) ethanol preparation, the main band
with ρ=1.019 was still accompanied by the “empty liposomes”
band, while at 50% (v/v) ethanol, there was no “empty
liposomes” band, and two closely spaced bands with ρ=1.014
and ρ=1.019 were detected. The preparation made at 60% (v/v)
ethanol showed a diffuse light-scattering area at the top of the
gradient, and a band of highly aggregated material having
ρ=1.028–1.030.
To determine if the mode of particle assembly affected the
particle size and composition, the gradients were fractioned
and analyzed for total DNA (by PicoGreen assay), and for two
lipid components, cationic (DOTAP) and neutral (POPC),
using multiple radioactive labels, [3H]-DDAB (cationic) and
[14C]-DPPC (neutral phospholipid), respectively. In addition,
the main bands were analyzed for particle size and DNA dye
accessibility (Table 7). The low density bands (ρ=1.007 or
less) were confirmed as having practically no DNA, while
various small amounts of free DNA were found in the bottom
fractions, consistent with the higher buoyant density of free
DNA (ρN1.050). In the isolated main bands, the smallest
particles (65–68 nm on average) with the most extensively
encapsulated DNA (dye accessibility 11–12%) were observed
in the preparations made in 40% (v/v) and 50% (v/v) ethanol.
However, the highest level of incorporation of both DNA and
lipid in the particles, reaching about 87–88% of the lipid and
practically quantitative for DNA, was observed in the prepa-
ration made at 50% (v/v) ethanol. This finding was consistentTable 7
Analysis of size, dye accessibility, lipid and DNA content of purified complexes
from a sucrose gradient
Tube ID % Ethanol % D.A. Size (nm) %
DOTAP
%
POPC
%
DNA
A 0 71.3±4.4 450.4±210.6 79.3 77.8 82.7
B 20 42.6±3.4 104.6±46.3 49.1 44.1 90.8
C 30 46.1±3.9 177.6±71.4 39.5 34.5 92.2
D 40 11.1±1.6 67.8±31.9 58.2 54.1 90.2
E 50 11.8±0.7 64.9±28.4 88.3 86.8 99.5
F 60 16.2±0.8 N/A 21.6 16.8 91.2
Examination of the main bands taken from the sucrose gradients of the
complexes prepared from 0 to 60% vol. ethanol. Size was measured by
quasielastic light scattering; lipid was quantified by scintillation counting and
DNA dye accessibility (% D.A.). Total DNA content was measured by
PicoGreen analysis.with the absence of the “empty liposome” band on the
gradient, and also with the fact that the particle composition
(lipid/DNA ratios) closely approximated the theoretical value
of 6.0 (DOTAP/DNA) and 15.0 (POPC/DNA) (Table 7). We
did not find any differences in the composition or other
properties between the particles in the closely spaced bands
recovered from the 50% (v/v) ethanol preparation. In the
preparation at 40% (v/v) ethanol only about 55–60% of the
lipid was incorporated, resulting in heavier (more DNA-rich)
particles and substantial amount of free lipid. In the
preparation produced at 60% (v/v) ethanol, the particles were
grossly aggregated, but DNA was well encapsulated (dye
accessibility 16%) compared to lipoplexes (71%). These
particles were also poor in lipid, containing only about one
fifth of the added lipid material. This finding is consistent with
the hypothesis that in the 60% (v/v) ethanol preparation, the
DNA prior to encapsulation has partially aggregated due to the
higher ethanol concentration resulting in lower surface area
available for lipid assembly. The PEDL material (30% (v/v)
ethanol) after centrifugation showed an increase in size (from
113 nm to 180 nm average), a moderate degree of DNA
encapsulation (dye accessibility 46%), and substantial amount
(approx. 60%) of lipid present in the non-DNA bound form.
Thus, the amount of ethanol in the monophase used to
assemble the DNA–lipid particles had a profound effect on the
particle composition and properties of the particles assembled
under the mutual solubility conditions. Preparation of com-
plexes with a monophase consisting of 50% (v/v) ethanol
showed the highest encapsulation of DNA and lipid, small
size, and low level of DNA exposure to the environment.
3.8. Lamellarity of particles
Using a non-membrane penetrating antibody that recognizes
and selectively quenches the carboxyfluorescein fluorophore
(anti-fluorescein IgG) to approximately 7% of its fluorescence
intensity [17], we estimated the proportion of EPE with a
carboxyfluorescein headgroup exposed on the surface of the
particles and used this as an indication of the degree of
lamellarity of the particles (Table 8). We found that all particles
prepared from aqueous ethanol solutions, except those formed
at 60% (v/v) ethanol, had 49–64% of the CF-labeled lipid
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particles with contained less than 20% of the lipid on the outside
of the particles. The particles formed at 60% (v/v) ethanol had
somewhat increased amount of lipid exposed on the surface.
This finding, along with the lower particle aggregation stability
and higher buoyant density (Fig. 3C) suggested that, at this
ethanol concentration, the particles assembled differently,
perhaps due to the partial loss of molecular solubility of the
DNA. As a control, 0.05 μm extruded liposomes of the same
formulation were tested and gave a quenching value (58%)
consistent with a unilamellar vesicle with a slight transmem-
brane lipid density asymmetry originating from the bilayer
curvature.
3.9. In vitro transfection activity of particles made in 0, 30 and
50% (v/v) ethanol/water mixtures
To correlate the mode of particle assembly with their capacity
to deliver functional DNA into living cells, we studied the levels
of transgene (luciferase) expression by cultured cells exposed to
the particles containing a luciferase-encoding plasmid. A human
HER2-specific scFv antibody–lipid conjugate, F5-PEG-DSPE,
was added to a portion of each set of particles. This ligand can
induce internalization and has been used previously with anti-
HER2 immunoliposomes for the targeted drug delivery to HER2
(c-erbB-2,neu) over-expressing cancers [4,18]. Lipofectamine
2000 was used as positive control to confirm the activity of the
luciferase encoded plasmid (Table 9). All three DNA–lipid
preparations (lipoplexes, PEDL and Genospheres) had the same
lipid andDNA composition andwere incubated with the cells for
12 h. The addition of an internalizable targeting ligand F5-PEG-
DSPE conferred an increase of transfection activity in all cases,
the highest activity enhancement occurring for Genospheres
(over 20-fold). Thus, DNA packaging into lipid particles using
Genosphere process did not adversely affect the transfectionTable 9
Luciferase expression in HER2 overexpressing human breast cancer cells
SKBR3, transfected with DNA–lipid complexes prepared in 0, 30 and 50% (v/v)
ethanol/water mixtures
Sample Luc (ng/mg protein) T/NT
F5-DSPE Genospheres 21.04±4.1 15.8
Non-targeted Genospheres 1.33±0.5
F5-DSPE PEDL 5.3±0.64 2.7
Non-targeted PEDL 1.95±0.5
F5-DSPE Lipoplex 1.8±0.4 11.3
Non-targeted Lipoplex 0.16±0.07
Lipofectamine 2000 162.8±49.1
Plasmid DNA 0.003±0.005
Untreated cells 0.003±0.001
Particles that were made target specific by the addition of the highly
internalizable human anti-HER2 scFv antibody F5 (F5-PEG-DSPE) conjugate
were tested in parallel with non-targeted ones. The lipid formulation was
DOTAP/POPC/Chol in the molar ratios 6/15/10 nmol, respectively, per μg
DNA. Improved recovery of particles following sterilization by microfiltration,
could be achieved by the addition of 2 mol% of a neutral PEG-lipid derivative
(PEG-DSG) to the initial lipid formulations. PEG-DSG was included into the
lipoplex formulation post DNA–lipid complexation under aseptic conditions by
a procedure adapted from Hong et al. [5].properties of the plasmid and in fact enhanced it over the other
DNA–lipid complexes tested.
4. Discussion
Non-viral vectors are generally prepared by the assembly of
nucleic acids with carrier components, such as lipids. Lipids
because of their amphiphilic nature have a propensity to self-
assemble into more or less stable structures. Interactions of
nucleic acids with self-assembled lipid structures depend in
large part on the ability of the lipid molecules in the structures to
undergo rearrangements as a result of the interaction. This
ability is hindered by strong attraction between the assembled
lipid molecules. Therefore, the lipid–nucleic acid complexes
obtained from lipids self-assembled into bilayers are heteroge-
neous [19] and with time undergo slow changes known as
“maturation” [20]. Reproducible assembly of particles can be
aided by weakening the intermolecular interactions between the
lipid molecules leading to a reduction or elimination of the
kinetically limited component in the nucleic acid–lipid inter-
actions. This has been accomplished by solubilizing the lipid
with a dialyzable detergent [21] or through destabilizing
preformed lipid bilayers with 30%–40% ethanol [3]. Alterna-
tively, DNA in the form of its cationic lipid salt was extracted
into organic phases, in which DNA would not be ordinarily
soluble [22,23].
We explored the possibility of assembling the DNA–lipid
particle in the environment where particle-forming lipids would
not form a condensed phase beyond a micelle, and DNAwould
still be soluble by itself. We found that such conditions could be
satisfied in a number of different organic solvent/water
mixtures. For the purpose of establishing the feasibility of this
approach, we initially chose to use plasmid DNA, a common
vector for carrying an expressible transgene, and a combination
of lipids containing a DNA-binding, transfection-enhancing
cationic lipid DOTAP [24] a bilayer-forming neutral lipid,
POPC, and a membrane-rigidifying lipid, cholesterol in the
amount of 6/15/10 nmol/nmol/nmol per μg DNA. The average
molecular weight of a DNA base is 330 g mol−1, so one
microgram of DNA corresponds to approximately 3 nmol of
bases, i.e., 3 nmol of DNA phosphate. Genosphere particles
were formed with 6 nmol cationic lipid per μg DNA, giving a N
(CH3)3
+/PO4
− ratio of 2. This was enough cationic lipid to
completely neutralize the DNA phosphate charge and ensure
stability during formation of the particle. Therefore, Geno-
spheres were constructed with a minimum of excess cationic
lipid, which is known to endow lipid–DNA complexes with
tropism toward the elements of capillary wall [25] and which
may interfere with the ability of the complexes to reach the
intended anatomical target.
Of the solvent mixtures tested, we found that 40%
isopropanol and 50% (v/v) ethanol solutions were ideal in this
respect, as they produced optically transparent lipid solutions
(Fig. 2) and upon combining DNA and lipid in such mixtures,
subsequently produced small, homogenous DNA–lipid particles
(Fig. 3A, Table 1). We then sought to see if this methodology
would entrap nucleic acids of varying size and chemical
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pping both small double and single stranded nucleic acid
molecules (Fig. 3B, Table 2). In addition, entrapment by this
method was also relatively insensitive to the chemical com-
position of the backbone linkages (phosphodiester of plasmid
and siRNA versus phosphorothioate of oligonucleotide) and
base composition (RNAvs. DNA) of the nucleic acid used. Also,
the fact that the resultant particles had similar sizes, while the
nucleic acid component size ranged from a single stranded 20
nucleotide oligo to 4.5 kbp plasmid indicates that the nucleic
acid molecular size does not dictate the overall particle size.
Taking one such monophase composition, i.e., 50% (v/v)
ethanol, the particles (“Genospheres”) were then compared to
particles produced using stable liposomes and from ethanol-
destabilized liposomes (PEDL) by the methods described by
Felgner et al. [2] and Maurer et al. [3], respectively, using
identical plasmid DNA and lipid compositions. While the
components of these three types of formulations were identical,
the resulting particles differed by their size, the degree of DNA
exposure, homogeneity of the preparations, and the complete-
ness of DNA and/or lipid incorporation.
It was of interest to assess the state of DNA condensation in
the DNA–lipid particles obtained by different methods. DNA
condensation has been observed in solution in many instances
using cationic multivalent salts such as spermidine3+ and cobalt
hexamine3+ [26]. Cationic polymers such as poly-L-lysine, [27],
cationic peptides [28], polyethylenimine [29] and dimerizable
surfactants [30] have been used to condense DNA in the
formation of DNA–lipid particles. It has been suggested that
charge neutralization of DNA by monovalent cationic lipids,
also results in compaction of DNA within these types of
complexes [31]. To measure the extent of DNA compaction
within the different particles, we used a simple approach,
measuring the FRET between an intercalating donor/acceptor
fluorescent DNA label pair YOYO-1 and EthD-2 (Table 3),
respectively. These bis-intercalating probes bind to DNA with
sufficient affinity and YOYO-1 has been used previously as
probe for DNA condensation [32], where it was shown that
electronic interactions among YOYO-1 molecules at high dye/
nucleotide ratios (1:50) led to a decrease in the probe quantum
yield during condensation. We used a lower YOYO-1 dye/
nucleotide ratio (1:200), where the fluorescence was unaffected
by condensation. Also, it was shown that DNA bound YOYO-1
was not displaced by the binding of PEI or CTAB [32]. As the
DNA is compacted, the sparsely distributed DNA-bound
YOYO-1 and EthD-2 molecules become closer to each other,
and the magnitude of FRET increases. Indeed, when both
probes were bound to plasmid DNA the FRET parameter was
0.6 or less, compared to the simple sum of DNA-bound YOYO-
1 or EthD-2 spectra recorded at the same concentrations. How-
ever, in the presence of spermidine, a known DNA-condensing
agent, the FRET value increased to 6.0–8.0. The increase in
EthD-2 emission intensity due to FRET after the addition of
spermidine suggests that EthD-2 is also not displaced from
DNA either in aqueous or aqueous ethanol mixtures.
Assuming that E values greater than 6 (DNA with large
excess of spermidine) correspond to highly condensed plasmid,and values less than 0.6 reflect an uncondensed state, it appears
that DNA inside all of the studied lipid complexes was far from
being highly condensed, but was compacted slightly with E
values ranging from 0.8 to 2.1.
Differences in the mechanism of particle formation between
Genospheres and PEDL were apparent when the proximity of
cationic and neutral dialkyl-lipids to the DNAwas studied using
FRET between a DNA-bound probe and a fluorescent cationic
lipid probe (DiI) or neutral lipid probe (DiI-DS) (Table 4). As a
control, we demonstrated that when mixed with so called
“helper” lipid (DOPE) in a liposome formulation DiI(3)
behaved as a cationic lipid, by electrostatically interacting with
DNA, forming large complexes and that DiI(3)-DS behaved as a
neutral lipid by not reacting with the polyanionic DNA. This
functional similarity produced further evidence for fitness of these
the cationic and neutral DiI lipid dyes as probes for the position of
cationic or the neutral dialkyl lipids used in the present FRET
study in the structure of DNA–lipid complex assemblies.
The data suggests that during Genosphere formation,
cationic lipid is first to assemble around the DNA, while
neutral lipid remains in solution. When the solution is cooled,
neutral lipid joins the lipid moiety around the DNA, and after
ethanol removal both types of lipid are at equal distance from
DNA in the resulting particle. During the formation of PEDL at
60 °C, both lipids are equidistant from DNA from the begin-
ning, indicating that the lipid vesicle interacts with the DNA as a
whole. When the temperature drops, the cationic lipid becomes
closer to DNA. When DNA interacted with preformed stable
liposomes, the relative distances of cationic and dialkyl-neutral
lipids to DNA in the resulting complex were also very similar
throughout the procedure. Thus, unlike Genospheres, the PEDL
and liposome–DNA complexes are likely to be formed through
deformation of the mixed condensed lipid phases without their
dissociation into lipid components.
These conclusions were in agreement with the results of a
FRET study measuring relative proximities of cationic (DiIC18
(3)) and dialkyl-neutral lipid (NBD-PE) in aqueous ethanol
solutions in the presence or absence of DNA (Table 5). In 30%
(v/v) ethanol at 60 °C (DNA absent), there was appreciable
amount of FRET measured, indicating the presence of a mixed
condensed lipid phase. In contrast, in 50% (v/v) ethanol at the
same temperature (DNA absent) practically no FRET was
detectable, indicating the cationic and neutral lipids were at
significant distances from each other. This was consistent with
the light scattering data indicating the absence of lipid
condensed phases in 50% (v/v) ethanol. However, when DNA
is added in the 50% (v/v) ethanol case (Genosphere), FRETwas
only measured when the ethanolic solution was cooled. This
suggests that cationic and dialkyl-neutral lipids are spaced far
from each other when DNA is present at 60 °C, but assume a
closer proximity when cooled to 22 °C. Together with the results
demonstrating at 60 °C in 50% (v/v) ethanol, cationic lipid is
close to DNA and neutral lipid is not, we can see that
Genosphere formation is a multi-step process with the cooling
step importantly allowing the dialkyl-neutral lipid to condense
on the DNA–cationic lipid complex in such a way that both
types of lipid are equidistant from DNA. Removal of ethanol
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to each other (Table 5).
Alternatively, the case of PEDL, FRET was measurable
initially in the presence of DNA and increased upon cooling.
This implies that both type of lipids are close to DNA during the
initial mixing step and during cooling and subsequent ethanol
removal, cationic lipid moves closer to DNA. This is similar to
the lipoplex situation, where both lipids are equally spaced from
DNA (Table 4) and are relatively close to each other in the final
complex (Table 5). At the present, we can only account for the
neutral dialkyl-lipid (POPC) distribution within the complexes
as this was reported to us by the structurally similar DiI(3)-DS.
However, the neutral lipid pool also contains cholesterol and its
distribution is at this time unclear. This will be the subject of a
future study. Also, we must point out that the described studies
give information on relative DNA and lipid molecular orga-
nization at defined points during the particle assembly process,
and as yet we have no data regarding rates of assembly for
individual components of the complexes.
As controls for the FRET studies, “minus one” principle was
used, where the matching liposomes, lipoplexes, or complexes
having just one of the FRET pair members were used to assess a
zero-FRET intensities, matching the actual environment of these
probes in the samples containing both FRET members. This is
because the fluorescent intensity of a probe may depend on the
environment of the probe, including the aggregate state of the lipids
surrounding the probe, and on the chemical composition of the
probe environment. Therefore, by using the zero-FRET controls
with identical lipid/DNA composition and method of preparation,
the effects of lipid environment on the FRET probes were ac-
counted for. In addition, we included the correction for light scat-
tering/autofluorescence control, using similarly prepared
complexes without any of the FRET pair labels.
Therefore, despite differences in the manner of the lipid
attachment to DNA among the three complexation methodologies,
the extent of DNA compaction and the relative proximity of the
lipids to DNA and of the cationic lipids to neutral lipids in the
resulting particles were similar. However, the particles differed by
their size, lamellarity, and DNA dye accessibility. Genospheres and
PEDL were relatively small with average particle diameter of
approximately 66 nm and 87 nm, respectively, lipoplexes were
considerably larger (greater than 200 nm) (Table 6).Accessibility of
encapsulated DNA to small molecules, such as enzymes (e.g.,
DNase) is to be avoided if functionally intact nucleic acids are to be
delivered. Therefore, the degree of DNA exposure to its
environment is an important characteristic of a synthetic delivery
vector and can be measured by a DNA-binding dye accessibility
assay. Of all three types of DNA–lipid particles tested, Geno-
spheres had the lowest dye accessibility (Table 6). Differences in
the observed DNA accessibility may result from differences in the
DNA encapsulation mechanisms leading to DNA exposure, or
from the non-homogeneity of particle preparation, such as the
presence of particle species with incomplete encapsulation and/or
surface-bound DNA molecules.
Differences in the relative DNA/lipid content in the particles
would result in different buoyant densities. Therefore,we employed
ultracentrifugation on a sucrose density gradient to analyze thehomogeneity of the particles made by plasmid DNA–lipid com-
plexation in aqueous solutions containing no ethanol or 20–60%
(v/v) ethanol, with subsequent ethanol removal by dialysis (Fig. 3C
and Table 7). The preparations showed at least one distinct, primary
light-scattering band, and sometimes a second distinct band, cor-
responding to different particle densities. The lipid and DNA
amounts in the main bands varied among the preparations made at
different ethanol concentrations. While the amount of DNA
incorporated into the particles of the main band was consistently
above 80% (v/v), the amount of incorporated lipid in the particles
produced in the presence of 20–40% (v/v) ethanol and at 60% (v/v)
ethanol was quite incomplete (16–58%) resulting in “heavy” bands
with higher DNA content, accompanied (in 30 and 40% (v/v)
ethanol preparations), with a light band of “empty” liposomes that
did not contain any significant amount of DNA. Unexpectedly, in
the particles produced at 50% (v/v) ethanol, i.e., using the
Genosphere method, the incorporation of both DNA and the lipid
was practically complete (86–99%). The particles showed two
closely spaced bands whose lipid and DNA compositions were the
same. The narrow distribution of particle density and closeness of
the composition of purified complexes to the relative composition
of the original starting materials pointed to the homogenous nature
of the Genosphere preparation.
Measurements of the proportion of the lipids exposed on the
surface of the particles produced in aqueous ethanol solutions
are consistent with the oligolamellar structure (Table 8). This is
in contrast to the lipoplex particles with contain less than 20%
of the lipid on the outside of the particles, thus indicating
numerous bilayers, as described previously [16,33,34]. Parti-
cles produced using the Genosphere, PEDL and lipoplex
methodologies had different levels of transfection activity in
cell culture (Table 9). While the absolute levels of activity were
lower than the positive control prepared using Lipofectamine
2000, optimized for in vitro gene transfer, these data show that
small DNA–lipid particles containing lipid-protected DNA,
can give similar levels of transfection activity to the large
lipoplex complexes of a similar composition. In fact, Geno-
spheres gave the highest activity, possibly due to the well-
protected nature of the DNA encapsulation. Also, the particles
of all three types could be rendered targetable by non-covalent
association with an amphipathic ligand–lipopolymer conjugate
in a manner similar to production of antibody-targeted
immunoliposomes [4,10] and more than an order of magnitude
enhancement of activity was observed for Genospheres. In
light of the results from previous studies suggesting that larger
non-targeted complexes are more active at delivering DNA in
vitro [35], it was important to demonstrate that small particles
made from a monophase did not in some way render the
resulting targeted particles inactive. The fact that the same lipid
formulation when processed in such a way that produced small
uniform particles (Genosphere), elicited higher transfection
activity that that obtained from the sonicated liposome/DNA
complex was surprising. As Genospheres are designed
ultimately for systemic administration as an injectable
therapeutic gene delivery vehicle, this finding is advantageous
and important in light of the poor pharmacokinetic character-
istics often associated with lipoplexes [36,37].
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presence of 50% (v/v) aqueous ethanol showed a number of
beneficial properties (small, uniform size; uniform density; high
degree of incorporation of both DNA and the lipid; and low DNA
exposure), without the need for a large excess of cationic lipid.We
hypothesize that these properties are a result of conducting the
DNA–lipid complexation under the conditions where both lipids
and DNA independently form molecular (true) or micellar
solutions, therefore the assembly of the particles does not require
rearrangements of pre-formed condensed phases (e.g., bilayers)
that introduce a high activation energy, kinetically slow reaction
step. Instead, we speculate that high efficiency ofDNAentrapment
is due to the high degree of utilization of the cationic lipid to
augment the hydrophobic character of the DNA molecule, as a
result of freer movement of molecularly-or micellarly-dissolved
cationic lipid component at the early stage of Genosphere
assembly. This is supported by our observations on the cationic
versus neutral lipid proximity to DNA during the Genosphere
assembly process. The existence of areas of mutual independent
solubility of DNA and a cationic surfactant in alcohol–water
solutions has been reported by Sergeyev et al [38]. The apparent
long axis length of T4 phage DNAwithin a DNA-CTAB complex
measured by fluorescence microscopy revealed a globule–coil–
globule transition of DNA at elevated alcohol concentration. At
intermediate ethanol concentrations 40–60% (v/v) the complex
was solubilized due to the transfer of CTAB into solution, and
DNA relaxed from a globule into a random coil conformation. At
higher ethanol contents, the DNA compacted into a globule be-
cause of the loss of solubility, and at lower ethanol concentrations,
the DNAwas compacted by the assembling detergent molecules.
This window of mutually independent solubility of DNA and
CTAB is remarkably similar to the ethanol concentration window
that produces Genospheres. We proposed that using 50% (v/v)
ethanol to separately solubilize the particle components is ideal in
this respect. Furthermore, while ethanol has an advantage of being
quite acceptable in the pharmaceutical manufacturing process, it is
very likely that other water-miscible organic solvents, such as
isopropanol can be used instead of ethanol at concentrations pro-
viding for independent solubility of both nucleic acid and lipid
components. Perhaps more important is the requirement that the
organic solvent maintains complete water miscibility during its
removal from the DNA–lipid mixture, leaving water behind. The
systems that separate phases at increasing water content [23], even
if at first homogenous, eventually lead to extraction of the DNA–
lipid complex in the organic-rich phase, thus preventing efficient
particle assembly.
By varying the concentration of ethanol in a water-organic
monophase, wewere able to compare the assembly of DNA–lipid
nanoparticles in the systems with identical DNA and lipid com-
positions in three different modes: DNA association with stable
cationic liposomes (lipoplex process, no ethanol); DNA associ-
ation with ethanol-destabilized liposomes (PEDL process, 30%
(v/v) ethanol), and DNA association with molecularly or
micellarly dissolved lipids (Genosphere process, 50% (v/v) etha-
nol). All three processes resulted in DNA–lipid particles with
nearly identical DNA compaction, lipid–DNA proximity.
However, it was only the Genosphere methodology that producedparticles that also were small, homogenous with respect to
composition, contained well-protected DNA, and resulted in 90%
or better incorporation of both DNA and the lipids. The
underlying mechanism of this unexpected finding is not yet
clear. A two-step assembly may be envisioned as a viable
hypothesis. At the first (germination) step, upon mixing of DNA
and the lipids in 50% (v/v) ethanol, uncoiled DNA molecules
interact with at least a portion of the cationic lipid component to
form partially compacted cationic lipid–DNA complexes, while
neutral lipids are still in solution. At the second (deposition) step,
upon cooling, the solubility of neutral and/or excess cationic lipid
components decreases and causes them to self-assemble into
neutral or mixed neutral-cationic lipid bilayers which are
deposited around pre-formed cationic lipid–DNA complexes
acting as colloidal germini for the assembly. The deposition
continues until the lipids are exhausted from solution, thus leading
to uniform and nearly quantitative inclusion of both lipid and
DNA into the particles. The fact that Genospheres gave the
highest in vitro transfection activity with the most targeting
enhancement of activity may be attributable to these features of
high DNA protection and particle uniformity.
The Genosphere process also offers advantages in manufactur-
ing, which is an important consideration for the clinical translation
of any pharmaceutical technology. It is a one-pot process that takes
place under near equilibrium conditions, without the need for
mechanical shearing steps such as dispersion, membrane extrusion
or microfluidization, to pre-formulate the lipids into liposomes or
post-formulate the lipid–DNAcomplexes into a nano-sized format.
It involves essentially two well-scalable operations, temperature-
controlled solution mixing and ethanol removal; the latter can be
conveniently scaled up using tangential flow ultrafiltration or
hollow fiber dialysis, the procedures quite common in pharmaceu-
tical manufacturing. The process does not use toxic solvents, such
as chloroform or methanol, and resulting nanoparticle preparations
are sterilizable by microfiltration.
Uniquely, DNA and lipid were separately solubilized in an
identical aqueous-solvent monophase, thereby avoiding areas of
variable solvent concentrations during the mixing step. The mixing
of two different solvents in such a process could place more critical
importance on the rate of mixing so that non-uniformities of the
resulting particles do not occur.
In this study, we focused on the general features and physico-
chemical characterization of Genospheres and the Genosphere
process. The studies of particle stability upon storage and in the
presence of blood plasma, as well as of the effect of particle lipid
composition on the surface charge, transfection properties, and
antibody-directed targeting of Genospheres have been performed
with encouraging results, have been reported separately [1]. In
conclusion, we hope that the described Genosphere methodology
for the assembly of nano-sized, targetable nucleic acid delivery
systems will help to overcome current barriers in bringing nucleic
acid-based therapeutics into medical practice.
Appendix A. Supplementary data
Supplementary data associated with this article can be found
in the online version at doi:10.1016/j.bbamem.2006.03.020.
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